Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model without Pretreatment and its Pharmacokinetics after Intramuscular Administration

相似書籍

• The GluK1 (GluR5) Kainate/α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist LY293558 Reduces Soman-Induced Seizures and Neuropathology
  由: Figueiredo, Taiza H., et al.
  出版: (2011)
• Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population
  由: Apland, James P., et al.
  出版: (2018)
• LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety
  由: Prager, Eric M., et al.
  出版: (2014)
• Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology
  由: Apland, James P., et al.
  出版: (2010)
• A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists
  由: Miller, Steven L., et al.
  出版: (2015)